Literature DB >> 29036268

Breast Cancer Estrogen Receptor Status According to Biological Generation: US Black and White Women Born 1915-1979.

Nancy Krieger1, Jaquelyn L Jahn1, Pamela D Waterman1, Jarvis T Chen1.   

Abstract

Evidence suggests that contemporary population distributions of estrogen-receptor (ER) status among breast cancer patients may be shaped by earlier major societal events, such as the 1965 abolition of legal racial discrimination in the United States (state and local "Jim Crow" laws) and the Great Famine in China (1959-1961). We analyzed changes in ER status in relation to Jim Crow birthplace among the 46,417 black and 339,830 white US-born, non-Hispanic women in the Surveillance, Epidemiology, and End Results (SEER) 13 Registry Group who were born between 1915 and 1979 and diagnosed (ages 25-84 years, inclusive) during 1992-2012. We grouped the cases according to birth cohort and quantified the rate of change using the haldane (which scales change in relation to biological generation). The percentage of ER-positive cases rose according to birth cohort (1915-1919 to 1975-1979) only among women diagnosed before age 55. Changes according to biological generation were greater among black women than among white women, and among black women, they were greatest among those born in Jim Crow (versus non-Jim Crow) states, with this group being the only group to exhibit high haldane values (>|0.3|, indicating high rate of change). Our study's analytical approach and findings underscore the need to consider history and societal context when analyzing ER status among breast cancer patients and racial/ethnic inequities in its distribution.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29036268     DOI: 10.1093/aje/kwx312

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Response to Krieger.

Authors:  Brittny C Davis Lynn; Pavel Chernyavskiy; Gretchen L Gierach; Philip S Rosenberg
Journal:  J Natl Cancer Inst       Date:  2022-09-09       Impact factor: 11.816

2.  RE: Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.

Authors:  Nancy Krieger
Journal:  J Natl Cancer Inst       Date:  2022-09-09       Impact factor: 11.816

3.  Breast Cancer Incidence, Hormone Receptor Status, Historical Redlining, and Current Neighborhood Characteristics in Massachusetts, 2005-2015.

Authors:  Emily Wright; Pamela D Waterman; Christian Testa; Jarvis T Chen; Nancy Krieger
Journal:  JNCI Cancer Spectr       Date:  2022-03-02

4.  Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.

Authors:  Alexander P Cole; Peter Herzog; Hari S Iyer; Maya Marchese; Brandon A Mahal; Stuart R Lipsitz; Joshua Nyambose; Susan T Gershman; Mark Kennedy; Gail Merriam; Timothy R Rebbeck; Quoc-Dien Trinh
Journal:  Cancer       Date:  2021-05-17       Impact factor: 6.921

Review 5.  Health Behaviors and Lifestyle Interventions in African American Breast Cancer Survivors: A Review.

Authors:  Raheem J Paxton; William Garner; Lorraine T Dean; Georgiana Logan; Kristen Allen-Watts
Journal:  Front Oncol       Date:  2019-01-22       Impact factor: 6.244

Review 6.  The Intersection of Rural Residence and Minority Race/Ethnicity in Cancer Disparities in the United States.

Authors:  Whitney E Zahnd; Cathryn Murphy; Marie Knoll; Gabriel A Benavidez; Kelsey R Day; Radhika Ranganathan; Parthenia Luke; Anja Zgodic; Kewei Shi; Melinda A Merrell; Elizabeth L Crouch; Heather M Brandt; Jan M Eberth
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

7.  Structural Racism and Triple-Negative Breast Cancer Among Black and White Women in the United States.

Authors:  Linsey Eldridge; David Berrigan
Journal:  Health Equity       Date:  2022-02-14

8.  Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States.

Authors:  Kirsten M M Beyer; Yuhong Zhou; Purushottam W Laud; Emily L McGinley; Tina W F Yen; Courtney Jankowski; Nicole Rademacher; Sima Namin; Jamila Kwarteng; Sara Beltrán Ponce; Ann B Nattinger
Journal:  J Clin Oncol       Date:  2021-06-15       Impact factor: 50.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.